- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/112 - Salmonella; Shigella
Détention brevets de la classe A61K 39/112
Brevets de cette classe: 520
Historique des publications depuis 10 ans
41
|
35
|
40
|
32
|
30
|
41
|
46
|
33
|
26
|
8
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Glaxosmithkline Biologicals S.A. | 1701 |
34 |
University of Maryland, Baltimore | 999 |
23 |
Board of Trustees of the University of Arkansas | 771 |
13 |
Bharat Biotech International Limited | 94 |
10 |
University of Florida Research Foundation, Inc. | 3883 |
9 |
The Cleveland Clinic Foundation | 1591 |
8 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
8 |
The Texas a & M University System | 1519 |
8 |
Centre National de La Recherche Scientifique | 9632 |
7 |
Indian Council of Medical Research | 59 |
7 |
Institut Pasteur | 798 |
7 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
7 |
Boehringer Ingelheim Animal Health USA Inc. | 507 |
7 |
Arizona Board of Regents on behalf of Arizona State University | 2226 |
6 |
Children's Medical Center Corporation | 1780 |
6 |
Intervet Inc. | 848 |
6 |
Prokarium Limited | 21 |
6 |
Qu Biologics Inc. | 33 |
6 |
Cleveland BioLabs, Inc. | 22 |
6 |
The General Hospital Corporation | 4517 |
5 |
Autres propriétaires | 331 |